Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
Tecogen Inc (AMEX: TGEN) closed the day trading at $7.38 down -3.91% from the previous closing price of $7.68. In other words, the price has decreased by -$3.91 from its previous closing price. On the day, 0.86 million shares were traded. TGEN stock price reached its highest trading level at $8.18 during the session, while it also had its lowest trading level at $6.93.
Ratios:
For a better understanding of TGEN, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.67 and its Current Ratio is at 1.36. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Roth Capital on August 18, 2025, initiated with a Buy rating and assigned the stock a target price of $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when Lafaille Stephen bought 400 shares for $2.50 per share. The transaction valued at 1,000 led to the insider holds 400 shares of the business.
Lafaille Stephen sold 25,000 shares of TGEN for $149,500 on Jun 06 ’25. The VP of Business Development now owns 400 shares after completing the transaction at $5.98 per share. On Jun 04 ’25, another insider, Lafaille Stephen, who serves as the VP of Business Development of the company, sold 15,000 shares for $5.00 each. As a result, the insider received 75,000 and left with 400 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TGEN now has a Market Capitalization of 219118096 and an Enterprise Value of 221013600. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.34 while its Price-to-Book (P/B) ratio in mrq is 20.74. Its current Enterprise Value per Revenue stands at 8.411 whereas that against EBITDA is -70.301.
Stock Price History:
The Beta on a monthly basis for TGEN is 1.24, which has changed by 7.439561 over the last 52 weeks, in comparison to a change of 0.15085125 over the same period for the S&P500. Over the past 52 weeks, TGEN has reached a high of $12.07, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is -12.99%, while the 200-Day Moving Average is calculated to be 29.22%.
Shares Statistics:
Over the past 3-months, TGEN traded about 825.60K shares per day on average, while over the past 10 days, TGEN traded about 733830 shares per day. A total of 25.57M shares are outstanding, with a floating share count of 15.73M. Insiders hold about 47.01% of the company’s shares, while institutions hold 16.19% stake in the company. Shares short for TGEN as of 1761868800 were 1406262 with a Short Ratio of 1.70, compared to 1759190400 on 1355724. Therefore, it implies a Short% of Shares Outstanding of 1406262 and a Short% of Float of 6.64.
Earnings Estimates
As of right now, 1 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.17 and -$0.17 for the fiscal current year, implying an average EPS of -$0.17. EPS for the following year is -$0.05, with 1 analysts recommending between -$0.05 and -$0.05.
Revenue Estimates
For the next quarter, 1 analysts are estimating revenue of $8.42M. There is a high estimate of $8.42M for the next quarter, whereas the lowest estimate is $8.42M.
Based on 1 analysts’ estimates, the company’s revenue will be $42.78M in the next fiscal year. The high estimate is $42.78M and the low estimate is $42.78M.
